Order Article Reprints

Gkasdaris G, Berthiller J, Guyotat J, Jouanneau E, Gallet C, Meyronet D, Thomas L, Cartalat S, Seyve A, Honnorat J, et al. Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases. Cancers. 2024; 16(20):3465. https://doi.org/10.3390/cancers16203465

Gkasdaris, Grigorios, Julien Berthiller, Jacques Guyotat, Emmanuel Jouanneau, Clémentine Gallet, David Meyronet, Laure Thomas, Stéphanie Cartalat, Antoine Seyve, Jérôme Honnorat, and et al. 2024. "Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases" Cancers 16, no. 20: 3465. https://doi.org/10.3390/cancers16203465

Gkasdaris, G., Berthiller, J., Guyotat, J., Jouanneau, E., Gallet, C., Meyronet, D., Thomas, L., Cartalat, S., Seyve, A., Honnorat, J., Ducray, F., & Picart, T. (2024). Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases. Cancers, 16(20), 3465. https://doi.org/10.3390/cancers16203465